BEAT Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 10.32%, SMA50 -22.56%, SMA200 -1.01%). The stock’s 14-day RSI is 49.37 (neutral), while the ATR of 0.14 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -61.25% below its high and over 187.04% above its low. Average 10-day trading volume of 782.42 thousand shares is below the 3-month average of 1.37 million, indicating normal recent market interest.

HeartBeam, Inc. has 34.31 million shares outstanding. The public float is 26.81 million shares, elevated short interest at 0.74% of float. This equals 218.29 thousand shares. The short ratio is 2.2 days. Institutional investors hold 13.75% of the float. Insiders own 23.79%. STROME MARK E holds 3.65 million shares, Vajdic Branislav has 909.91 thousand shares and Elfrink Willem has 538.67 thousand shares. Over the past six months, insider transactions show net buying. They sold 307.15 thousand shares across 3 transactions.

HeartBeam, Inc. generated EPS of -$0.66 over the past year. Five-year average earnings growth is -61.91%. Wall Street analysts project EPS growth of 14.4% annually over the next five years. The latest quarter delivered EPS of -$0.12. The next quarter is forecast at -$0.14. Next year's EPS is expected at $26.88. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 8 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $8.00 to $2.50. The high target offers 769.57% upside. The low target suggests 171.74% downside. The mean target is $4.78. This offers 419.57% upside. HeartBeam, Inc. earnings surprise history is a mixed track record. The quarter that ended May 13, 2026, missed forecasts by -14.29%. The prior quarter beat by 7.69%. Over the last six quarters, Apple has recorded several small beats. These include -5.26% in March 13, 2025.

HeartBeam, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.13. This means the shares are trading above this model’s fair value.

HeartBeam, Inc. (NASDAQ:BEAT) closed at $0.90 USD, losing -$0.02 (-2.16%) from the previous close of $0.92. The stock is currently mid-range between its 52-week high and low $0.54 and $4.00. With a market capitalization of about $31.02 million, HeartBeam, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.87). Key stats such as the average daily volume over the past year has been around 1.50 million shares, volume is running light vs its 52-week average. Headquartered in Santa Clara, CA, HeartBeam, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Robert Eno, the company employs approximately 21 people and listed since November 11, 2021. HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting.

HeartBeam, Inc. trades at a P/E ratio of -1.85, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 59.06 reflecting a rich premium to book value. The P/FCF stands at -2.28, also above market averages. Compared to sector medians, HeartBeam, Inc. P/S is trading at a discount to the sector, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

HeartBeam, Inc. (NASDAQ:BEAT) shares are down -16.25% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows HeartBeam, Inc. trading at a premium to the broader market with a P/E of -1.85. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $6.04, suggesting 556.17% upside. Our AI forecast model points to short-term weakness (-10.92% over two weeks), a medium-term fall (-91.31% over three months), and a longer-term gain (485.55% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that HeartBeam, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -10.92%, with price expected at $0.82 by June 03, 2026, within a range of $0.69 to $0.95 3-Month Outlook: Projected fall of -91.31%, reaching $0.08 by August 19, 2026, with a range of $0.00 to $0.16. 1-Year Outlook: Projected gain of 485.55%, with price at $5.39 by May 21, 2027, within a range of $1.36 to $7.25.